Coloplast A/S (CLPBY)
OTCMKTS · Delayed Price · Currency is USD
9.26
-0.16 (-1.70%)
Aug 6, 2025, 3:59 PM EDT
Alteryx Market Cap
Coloplast has a market cap or net worth of $20.71 billion as of August 6, 2025. Its market cap has decreased by -26.37% in one year.
Market Cap
20.71B
Enterprise Value
24.38B
Revenue
4.03B
Ranking
n/a
PE Ratio
31.46
Stock Price
$9.26
Market Cap Chart
Since November 17, 1997, Coloplast's market cap has increased from 891.72M to 20.71B, an increase of 2,222.81%. That is a compound annual growth rate of 12.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 20.71B | -15.91% |
| Dec 30, 2024 | 24.63B | -4.23% |
| Dec 29, 2023 | 25.72B | 3.77% |
| Dec 30, 2022 | 24.79B | -33.55% |
| Dec 30, 2021 | 37.30B | 14.26% |
| Dec 30, 2020 | 32.65B | 23.84% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 532.81M |
| Glass House Brands | 467.07M |
| Northwest Biotherapeutics | 366.31M |
| CytoDyn | 347.26M |
| American Oncology Network | 330.70M |